The U.S. Defense Health Agency (DHA) has awarded a $763,200.00 firm fixed price purchase order contract to the Maryland Department of Health Laboratories Administration Division (MDHLAD) for newborn metabolic screening testing services. The contract has an ultimate completion date of May 30, 2029. MDHLAD, a division of the state government, will provide these services to support public health programs. The contract was not set aside for any specific business type. MDHLAD has previously received federal contracts from DHA and the Department of Homeland Security for newborn screening and biodetection services. Additionally, in 2022 MDHLAD was awarded a $3.6 million Economic Adjustment Assistance grant from the Department of Commerce to provide working capital assistance to small businesses impacted by COVID-19.
Generated 8/6/24, 11:00 AM